PDF) Does additional monitoring status increase the reporting of adverse drug reaction s ? An interrupted time series analysis of EudraVigilance data
Additional monitoring - information materials | European Medicines Agency
EU launches black triangle drug monitoring scheme - PMLiVE
Should Medicines With a PASS be Excluded From Additional Monitoring? EC Says Not Yet | RAPS
Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works. - Abstract - Europe PMC
APsystems upgrades EMA monitoring website with more data and improved interface - APsystems EMEA
conceptually similar components between Food and drug admin-... | Download Scientific Diagram
Monitoring evidence on overall survival benefits of anticancer drugs approved by the European Medicines Agency between 2009 and 2015 - ScienceDirect
EU ramps up collection of public health data to improve drug reviews | Reuters
Medicinal products under additional monitoring – NAMMDR
EMA
Monitoring of medical literature(MLM) | PPT
Medicines under additional monitoring in the European Union
Centralized procedure of Marketing Authorization: Procedural Advice
EMA updates SmPC and package leaflet templates with new black symbol | Signs & Symptoms of Translation
EMA survey on safety of medicines and reporting of adverse drug reactions – EFNA
4. EudraVigilance
1. Introduction
Medicines under additional monitoring in the European Union
Additional-monitoring factsheet (EN)
GVP Module Additional Monitoring
EMA updates SmPC and package leaflet templates with new black symbol | Signs & Symptoms of Translation
Communication campaign: medicines under additional monitoring
Communication campaign: medicines under additional monitoring
Evaluation of quantitative signal detection in EudraVigilance for orphan drugs: possible risk of false negatives | Semantic Scholar
IRISH MEDICINES BOARD ADDITIONAL MONITORING: BLACK TRIANGLE INTRODUCED AS PROMPT TO REPORT SUSPECTED ADVERSE REACTIONS
